Geode Capital Management LLC grew its holdings in Genpact Limited (NYSE:G – Free Report) by 2.5% during the 2nd quarter, Holdings Channel.com reports. The fund owned 3,645,967 shares of the business services provider’s stock after acquiring an additional 90,541 shares during the period. Geode Capital Management LLC’s holdings in Genpact were worth $160,480,000 at the end of the most recent reporting period.
Other institutional investors have also recently made changes to their positions in the company. Hussman Strategic Advisors Inc. bought a new position in Genpact in the 2nd quarter worth approximately $3,697,000. Access Investment Management LLC bought a new position in shares of Genpact during the second quarter worth $9,423,000. Strs Ohio grew its stake in Genpact by 51.4% during the second quarter. Strs Ohio now owns 56,217 shares of the business services provider’s stock valued at $2,474,000 after acquiring an additional 19,075 shares in the last quarter. Asset Management One Co. Ltd. increased its holdings in Genpact by 149.5% in the 2nd quarter. Asset Management One Co. Ltd. now owns 33,618 shares of the business services provider’s stock valued at $1,480,000 after acquiring an additional 20,146 shares during the last quarter. Finally, Sumitomo Mitsui Trust Group Inc. lifted its stake in Genpact by 8.8% in the 2nd quarter. Sumitomo Mitsui Trust Group Inc. now owns 2,501,688 shares of the business services provider’s stock worth $110,099,000 after purchasing an additional 203,015 shares in the last quarter. Hedge funds and other institutional investors own 96.03% of the company’s stock.
Genpact Price Performance
Shares of Genpact stock opened at $43.78 on Wednesday. The stock has a market cap of $7.55 billion, a price-to-earnings ratio of 14.12, a price-to-earnings-growth ratio of 1.40 and a beta of 0.85. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.51 and a current ratio of 1.51. The stock has a 50 day moving average price of $41.11 and a 200-day moving average price of $43.08. Genpact Limited has a one year low of $37.49 and a one year high of $56.76.
Genpact Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 23rd. Investors of record on Tuesday, December 9th will be issued a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 1.6%. The ex-dividend date is Tuesday, December 9th. Genpact’s dividend payout ratio is presently 21.94%.
Insider Activity
In other news, Director Tamara Franklin sold 2,750 shares of the company’s stock in a transaction that occurred on Wednesday, November 12th. The stock was sold at an average price of $45.65, for a total transaction of $125,537.50. Following the transaction, the director owned 22,236 shares of the company’s stock, valued at approximately $1,015,073.40. This represents a 11.01% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, SVP Sameer Dewan sold 26,531 shares of the stock in a transaction that occurred on Tuesday, November 11th. The stock was sold at an average price of $44.70, for a total value of $1,185,935.70. Following the completion of the sale, the senior vice president owned 62,617 shares in the company, valued at approximately $2,798,979.90. The trade was a 29.76% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 161,183 shares of company stock valued at $6,970,760. Company insiders own 2.80% of the company’s stock.
Analyst Upgrades and Downgrades
Several brokerages have recently issued reports on G. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Genpact in a report on Wednesday, October 8th. Wall Street Zen upgraded Genpact from a “hold” rating to a “buy” rating in a report on Saturday. Needham & Company LLC upped their price objective on Genpact from $50.00 to $53.00 and gave the stock a “buy” rating in a report on Friday, August 8th. Citigroup raised shares of Genpact to a “hold” rating in a report on Thursday, October 23rd. Finally, JPMorgan Chase & Co. reduced their price target on shares of Genpact from $55.00 to $50.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 20th. Three investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $51.13.
Check Out Our Latest Report on G
Genpact Company Profile
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
See Also
- Five stocks we like better than Genpact
- Find and Profitably Trade Stocks at 52-Week Lows
- What’s on the Thanksgiving Table? A Stock Pick for Every Course
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Why Home Depot’s Pain Could Be a Long-Term Investor’s Gain
- How to Invest in Blue Chip Stocks
- Qualcomm’s Bulls Are Running Out of Room to Be Wrong
Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G – Free Report).
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.
